157 related articles for article (PubMed ID: 38228757)
1. Impact of serum eicosapentaenoic acid/arachidonic acid ratio on overall survival in lung cancer patients treated with pembrolizumab: a pilot study.
Tanaka I; Yano Y; Mori M; Manabe S; Fukuo K
Sci Rep; 2024 Jan; 14(1):1384. PubMed ID: 38228757
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of the association of the eicosapentaenoic acid/arachidonic acid ratio derived from fish consumption with the serum lipid levels: a pilot study.
Tani S; Matsuo R; Matsumoto N
Heart Vessels; 2019 Jan; 34(1):189-196. PubMed ID: 30014269
[TBL] [Abstract][Full Text] [Related]
3. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
4. The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study.
Nagata M; Hata J; Hirakawa Y; Mukai N; Yoshida D; Ohara T; Kishimoto H; Kawano H; Kitazono T; Kiyohara Y; Ninomiya T
J Epidemiol; 2017 Dec; 27(12):578-583. PubMed ID: 28669629
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study.
Nakanishi S; Hirukawa H; Shimoda M; Tatsumi F; Kohara K; Obata A; Okauchi S; Kinoshita T; Sanada J; Fushimi Y; Nishioka M; Kan Y; Tomita A; Mashiko A; Horiya M; Iwamoto Y; Mune T; Kaku K; Kaneto H
Lipids Health Dis; 2019 Jan; 18(1):36. PubMed ID: 30704490
[TBL] [Abstract][Full Text] [Related]
6. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.
Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T
Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Eicosapentaenoic Acid to Arachidonic Acid Ratio on Long-term Cardiovascular Events Following Percutaneous Coronary Intervention.
Niwa K; Tanaka A; Funakubo H; Otsuka S; Yoshioka N; Kudo N; Tobe A; Sakakibara K; Miki Y; Kataoka T; Furusawa K; Ishii H; Murohara T
Intern Med; 2021 Dec; 60(24):3865-3871. PubMed ID: 34148960
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio and Atherosclerotic Risk Factors in Patients With Peripheral Artery Disease.
Nishibe T; Dardik A; Nishibe M; Kano M; Matsumoto R; Nakano Y; Maekawa K; Irikata Y; Ogino H; Ono S; Koizumi J
Vasc Endovascular Surg; 2021 Feb; 55(2):112-116. PubMed ID: 33073735
[TBL] [Abstract][Full Text] [Related]
10. Association of serum eicosapentaenoic acid to arachidonic acid ratio with microalbuminuria in a population of community-dwelling Japanese.
Fukami A; Adachi H; Hirai Y; Enomoto M; Otsuka M; Kumagai E; Nakamura S; Yoshimura A; Obuchi A; Nohara Y; Nakao E; Hori K; Fukumoto Y
Atherosclerosis; 2015 Apr; 239(2):577-82. PubMed ID: 25734981
[TBL] [Abstract][Full Text] [Related]
11. A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy.
Hashimoto T; Ako J; Nakao K; Ozaki Y; Kimura K; Noguchi T; Yasuda S; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Uematsu M; Hirata K; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Toubaru T; Saku K; Ohshima S; Nakai M; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
Heart Vessels; 2018 May; 33(5):481-488. PubMed ID: 29147787
[TBL] [Abstract][Full Text] [Related]
12. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.
Nelson JR; Raskin S
Postgrad Med; 2019 May; 131(4):268-277. PubMed ID: 31063407
[TBL] [Abstract][Full Text] [Related]
13. The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy.
Tani S; Nagao K; Kawauchi K; Yagi T; Atsumi W; Matsuo R; Hirayama A
Am J Cardiovasc Drugs; 2017 Oct; 17(5):409-420. PubMed ID: 28634822
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the serum eicosapentanoic acid-to-arachidonic acid ratio and the severity of cerebral white matter hyperintensities in older adults with memory disorder.
Nagai K; Koshiba H; Shibata S; Matsui T; Kozaki K
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():48-52. PubMed ID: 26671157
[TBL] [Abstract][Full Text] [Related]
15. Association and Implications of Blood and Plaque n-3 Polyunsaturated Fatty Acid Composition in Patients Treated with Oral Eicosapentaenoic Acid before Carotid Endarterectomy.
Ishikawa T; Yamaguchi K; Funatsu T; Okada Y; Kawamata T
Int J Angiol; 2023 Dec; 32(4):238-242. PubMed ID: 37927834
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the ratio of eicosapentaenoic acid to arachidonic acid in an inland prefecture, Tochigi: Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD).
Kitagawa Y; Abe S; Toyoda S; Watanabe S; Ebisawa K; Murakami Y; Takahashi T; Sugimura H; Taguchi I; Inoue T
Intern Med; 2014; 53(3):177-82. PubMed ID: 24492684
[TBL] [Abstract][Full Text] [Related]
17. LC/ESI-MS/MS method for determination of salivary eicosapentaenoic acid concentration to arachidonic acid concentration ratio.
Ogawa S; Tomaru K; Matsumoto N; Watanabe S; Higashi T
Biomed Chromatogr; 2016 Jan; 30(1):29-34. PubMed ID: 25620210
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions.
Hishikari K; Kimura S; Yamakami Y; Kojima K; Sagawa Y; Otani H; Sugiyama T; Kuwahara T; Hikita H; Takahashi A; Isobe M
Atherosclerosis; 2015 Apr; 239(2):583-8. PubMed ID: 25733330
[TBL] [Abstract][Full Text] [Related]
19. Association between Preoperative Long-Chain Polyunsaturated Fatty Acids and Oxidative Stress Immediately after Total Knee Arthroplasty: A Pilot Study.
Kubo Y; Ikeya M; Sugiyama S; Takachu R; Tanaka M; Sugiura T; Kobori K; Kobori M
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205251
[TBL] [Abstract][Full Text] [Related]
20. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
